Precision proton beams take aim at High-Risk prostate tumors
NCT ID NCT03624660
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study tests whether a higher dose of proton radiation, focused on tumors seen on MRI, can better control high-risk prostate cancer. About 100 participants will receive radiation over 8-9 weeks, plus hormone therapy for 18 months. The goal is to lower the chance of cancer returning within 5 years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PROSTATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida Health Proton Therapy Institute
Jacksonville, Florida, 32206, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread
- Could a depression drug fight prostate cancer?
- New blood test aims to spot prostate cancer cells earlier
- Glow-in-the-Dark antibody could help surgeons spot prostate cancer
- New radiation approach shows promise for prostate cancer control
- High-dose radiation aims to control tough prostate cancer